Stock Research: Phibro Animal Health

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Phibro Animal Health

NasdaqGM:PAHC US71742Q1067
95
  • Value
    69
  • Growth
    93
  • Safety
    Safety
    96
  • Combined
    100
  • Sentiment
    22
  • 360° View
    360° View
    95
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Phibro Animal Health Corporation is a global animal health and mineral nutrition company. It operates in the animal health, mineral nutrition, and performance products industries. It markets its products in over 80 countries, primarily in North America. In the last fiscal year, the company had a market cap of $1,243 million, profits of $314 million, revenue of $1,018 million, and 1940 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 95 (better than 95% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Phibro Animal Health are very positive. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Phibro Animal Health. The consolidated Value Rank has an attractive rank of 96, which means that the share price of Phibro Animal Health is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 96% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 69. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 22. Professional investors are more confident in 78% other stocks. ...read more

more
Index
Dividends USA
NASDAQ
D.J. US Pharmaceutical
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
96 94 100 100
Growth
93 73 27 33
Safety
Safety
69 73 87 78
Sentiment
22 44 1 9
360° View
360° View
95 94 66 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
5 1 1 11
Opinions Change
50 95 21 50
Pro Holdings
n/a 86 19 74
Market Pulse
1 1 18 4
Sentiment
22 44 1 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
96 94 100 100
Growth
93 73 27 33
Safety Safety
69 73 87 78
Combined
100 100 95 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
63 58 69 59
Price vs. Earnings (P/E)
87 80 93 96
Price vs. Book (P/B)
32 35 50 39
Dividend Yield
90 92 98 98
Value
96 94 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
58 49 38 21
Profit Growth
85 82 34 46
Capital Growth
75 38 49 28
Stock Returns
87 93 45 77
Growth
93 73 27 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 19 21 21
Refinancing
75 72 89 71
Liquidity
74 74 80 77
Safety Safety
69 73 87 78

Similar Stocks

Discover high‑ranked alternatives to Phibro Animal Health and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.